Time course of cardiac rupture after acute myocardial infarction and comparison of clinical features of different rupture types.

Objective: This study aimed to investigate the time course of cardiac rupture (CR) after acute myocardial infarction (AMI) and the differences among different rupture types. Method: We retrospectively analyzed 145 patients with CR after AMI at Shanxi Cardiovascular Hospital from June 2016 to September 2022. Firstly, according to the time from onset of chest pain to CR, the patients were divided into early CR (≤24 h) (n = 61 patients) and late CR (>24 h) (n = 75 patients) to explore the difference between early CR and late CR. Secondly, according to the type of CR, the patients were divided into free wall rupture (FWR) (n = 55) and ventricular septal rupture (VSR) (n = 90) to explore the difference between FWR and VSR. Results: Multivariate logistic regression analysis showed that high white blood cell count (OR = 1.134, 95% CI: 1.019-1.260, P = 0.021), low creatinine (OR = 0.991, 95% CI: 0.982-0.999, P = 0.026) were independently associated with early CR. In addition, rapid heart rate (OR = 1.035, 95% CI: 1.009-1.061, P = 0.009), low systolic blood pressure (OR = 0.981, 95% CI: 0.962-1.000, P = 0.048), and anterior myocardial infarction (OR = 5.989, 95% CI: 1.978-18.136, P = 0.002) were independently associated with VSR. Conclusion: In patients with CR, high white blood cell count and low creatinine were independently associated with early CR, rapid heart rate, low systolic blood pressure, and anterior myocardial infarction were independently associated with VSR.

Comparison between guide plate navigation and virtual fixtures in robot-assisted osteotomy.

To verify the advantages of Virtual Fixtures (VFs) by comparing the result of guide plate navigation (GPN) and VFs in robot-assisted osteotomy. Robot-assisted surgery has been extensively applied in traditional orthopedic surgeries. It fundamentally improves surgeries' cutting accuracy. In addition, many key techniques have been applied in bone cutting to increase the procedure's safety in various ways. In this paper, two robot-assisted osteotomy methods are proposed. Three operators with no osteotomy experience performed plane cutting with the assistance of a robot. GPN and VFs were applied to assist the Sawbones cutting. Each operator has five attempts using each method to perform bone cutting, distance errors and angular errors were recorded. The advantage of Sawbones is that there is no influence from soft tissues and blood. It can give a more precise measurement. The results show that both methods have high accuracy with the robot's assistance. VFs have higher accuracy in comparison with GPN. With GPN, the mean distance and angular error of the three operators were 2.974 ± 0.282 mm and 4.737 ± 0.254°. With VFs, the mean range and angular error of the three operators were 1.857 ± 0.349 mm and 2.24 ± 0.123°, respectively. VFs limited the robot's end in the planned area, increasing the accuracy and safety of robot-assisted osteotomy.

Study on the Safety of the New Radial Artery Hemostasis Device.

Objective: At present, the use of particular radial hemostatic devices after coronary angiography (CAG) or percutaneous coronary intervention (PCI) has become the primary method of hemostasis. Most control studies are based on the products already on the market, while only a few studies are on the new hemostatic devices. The aim of this study is to compare a new radial artery hemostasis device which is transformed based on the invention patent (Application number: CN201510275446) with TR Band (Terumo Medical) to evaluate its clinical effects. Methods: In a prospective randomized clinical trial, 60 patients after CAG or PCI were randomly divided into two groups, patients in the trial group (CD group) using a new radial artery hemostasis device to stop bleeding and the control group (TR group) using the TR Band. The method is to collect relevant data of the two groups and compare the differences in hemostasis, local complications, and patient discomfort between the two groups. Results: The hemostatic devices in both groups achieved adequate hemostasis, and there was no failure to stop bleeding. The new radial artery hemostasis device was better than the TR band in pain and swelling (P < 0.05). There were no significant differences in bleeding, hematoma, ecchymosis, skin damage, and local infection between the two groups (P > 0.05). Conclusions: The sample of the new radial artery hemostasis device can stop bleeding effectively at the puncture site after CAG or PCI and is not inferior to the TR Band balloon hemostatic device in safety and is better in comfort.

Computer-aided automatic planning and biomechanical analysis of a novel arc screw for pelvic fracture internal fixation.

BACKGROUND AND OBJECTIVE: The sacroiliac joint screw is a common fixation method for pelvic posterior ring fractures. The complex anatomical structure around the pelvis makes it impossible to find a suitable fixed path, which increases the difficulty of surgical operation. In this paper, we propose an automatic planning algorithm based on a computer-aided internal arc fixation channel for pelvic fractures for the first time. METHODS: A channel generation algorithm based on seed derived points was designed, and the optimal channel was selected by scoring rules based on 3D erode algorithm for the generated channel. The biomechanical properties of the internal arc fixation screw and traditional internal straight fixation screw in three postures were compared using biomechanical finite element analysis. RESULTS: The proposed algorithm verified the existence of a more adaptable internal arc fixation channel and can quantitatively plan a relatively optimal constant-curvature internal arc fixation channel in pelvises of ten adults. Significantly high stresses concentrated around the interaction region between the screws and bone may increase the risk of bone fractures and screw loosening in the long term. The experimental results show that the internal arc fixation screw has better strain and deformation performance than the internal straight fixation screw. CONCLUSIONS: A novel arc internal fixation method for pelvic fractures was proposed to improve the safety and stability of screw fixation of pelvic fracture. The nonparametric test proved that the sacroiliac dislocation model repaired by internal arc fixation screw was significantly different from that repaired by internal straight fixation screw. The computer-aided automatic planning algorithm provides the possibility of robot-assisted pelvic fracture fixation.

Distal Transradial Access in Anatomical Snuffbox for Coronary Angiography and Intervention: An Updated Meta-Analysis.

OBJECTIVE: The previous meta-analysis has assessed that distal transradial access (dTRA) in anatomical snuffbox is safe and effective for coronary angiography and intervention and can reduce radial artery occlusion. However, since the publication of the previous meta-analysis, several observational studies have been added, so we performed an updated meta-analysis to include more eligible studies to compare distal transradial access in anatomical snuffbox with conventional transradial access (cTRA). METHOD: Pubmed, Embase, and Cochrane Library databases were searched for relevant studies from the literature published until 5 January 2021 to evaluate catheterization/puncture failure, hematoma, radial artery spasm, radial artery occlusion (RAO), access time, fluoroscopy time, radiation dose area product, total procedure time, and hemostatic device removal time. The pooled odds ratio (OR), weighted mean difference (WMD), and standardized mean difference (SMD) with 95% confidence interval (95% CI) were calculated for dichotomous and continuous variables, respectively. RESULTS: A total of 9,054 patients from 14 studies were included in the meta-analysis, and we found no significant difference in catheterization/puncture failure (OR = 1.94, 95CI [0.97, 3.86], P=0.06), hematoma (OR = 0.97, 95CI [0.55, 1.73], P=0.926), radial artery spasm (OR = 0.76, 95CI [0.43, 1.36], P=0.354), total procedure time (SMD = 0.23, 95CI [-0.21, 0.68], P=0.308), or radiation dose area product (WMD = 216.88 Gy/cm2, 95CI [-126.24, 560.00], P=0.215), but dTRA had a lower incidence of RAO (OR = 0.39, 95CI [0.23, 0.66], P < 0.001), shorter hemostatic device removal time (WMD = -66.62 min, 95CI [-76.68, -56.56], P < 0.001), longer access time (SMD = 0.32, 95CI [0.08, 0.56], P=0.008), and longer fluoroscopy time (SMD = 0.16, 95CI [-0.00, 0.33], P=0.05) than cTRA. CONCLUSION: Compared with the cTRA, the dTRA has a lower incidence of radial artery occlusion and shorter hemostatic device removal time, which is worthy of further evaluation in clinical practice.

Coronary heart disease and COVID-19: A meta-analysis.

OBJECTIVE: Since the World Health Organization (WHO) announced coronavirus disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number of infections has been increasing. The purpose of this meta-analysis was to investigate the prognosis of COVID-19 in patients with coronary heart disease. METHOD: Pubmed, Embase, and Cochrane Library databases were searched to collect the literature concerning coronary heart disease and COVID-19. The retrieval time was from inception to Nov 20, 2020, using Stata version 14.0 for meta-analysis. RESULTS: A total of 22,148 patients from 40 studies were included. The meta-analysis revealed that coronary heart disease was associated with poor prognosis of COVID-19 (OR=3.42, 95%CI [2.83, 4.13], P < 0.001). After subgroup analysis, coronary heart disease was found to be related to mortality (OR = 3.75, 95%CI [2.91, 4.82], P < 0.001), severe/critical COVID-19 (OR = 3.23, 95%CI [2.19, 4.77], P < 0.001), ICU admission (OR = 2.25, 95%CI [1.34, 3.79], P = 0.002), disease progression (OR = 3.01, 95%CI [1.46, 6.22], P = 0.003); Meta-regression showed that the association between coronary heart disease and poor prognosis of COVID-19 was affected by hypertension (P = 0.004), and subgroup analysis showed that compared with the proportion of hypertension >30% (OR = 2.85, 95%CI [2.33, 3.49]), the proportion of hypertension <30% (OR = 4.78, 95%CI [3.50, 6.51]) had a higher risk of poor prognosis. CONCLUSION: Coronary heart disease is a risk factor for poor prognosis in patients with COVID-19.

OBJETIVO: Desde que la Organización Mundial de la Salud (OMS) anunció que la enfermedad por coronavirus de 2019 (COVID-19) se había convertido en una pandemia global el 11 de marzo de 2020, se ha incrementado el número de infecciones. El objetivo de este metaanálisis fue investigar el pronóstico de la COVID-19 en pacientes con cardiopatía coronaria. MÉTODO: Se realizó una búsqueda en las bases de datos de Pubmed, Embase y Cochrane Library para reunir la literatura relativa a cardiopatía coronaria y COVID-19. El tiempo de recuperación de datos fue desde el inicio hasta el 20 de noviembre de 2020, utilizando la versión 14.0 de Stata® para el metaanálisis. RESULTADOS: Se incluyó un total de 22.148 pacientes de 40 estudios. El metaanálisis reveló que la cardiopatía coronaria estaba asociada a un mal pronóstico de COVID-19 (OR: 3,42; IC 95%: 2,83-4,13; p < 0,001). Tras el análisis de subgrupo, se encontró que la cardiopatía coronaria tenía relación con la mortalidad (OR: 3,75; IC 95%: 2,91-4,82; p < 0,001), COVID-19 grave/crítica (OR: 3,23; IC 95%: 2,19-4,77; p < 0,001), ingreso en la UCI (OR: 2,25; IC 95%: 1,34-3,79; p = 0,002), progresión de la enfermedad (OR: 3,01; IC 95%: 1,46-6,22; p = 0,003). La metarregresión reflejó que la asociación entre cardiopatía coronaria y mal pronóstico de la COVID-19 estaba influida por la hipertensión (p = 0,004), y el análisis de subgrupo mostró que comparada con la proporción de hipertensión > 30% (OR: 2,85; IC 95%: 2,33-3,49), la proporción de hipertensión < 30% (OR: 4,78; IC 95%: 3,50-6,51) tenía mayor riesgo de mal pronóstico. CONCLUSIÓN: La cardiopatía coronaria es un factor de riesgo de mal pronóstico en pacientes con COVID-19.

Coronary heart disease and COVID-19: A meta-analysis

Objective: Since the World Health Organization (WHO) announced coronavirus disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number of infections has been increasing. The purpose of this meta-analysis was to investigate the prognosis of COVID-19 in patients with coronary heart disease.MethodPubmed, Embase, and Cochrane Library databases were searched to collect the literature concerning coronary heart disease and COVID-19. The retrieval time was from inception to Nov 20, 2020, using Stata version 14.0 for meta-analysis.ResultsA total of 22,148 patients from 40 studies were included. The meta-analysis revealed that coronary heart disease was associated with poor prognosis of COVID-19 (OR=3.42, 95%CI [2.83, 4.13], P<0.001). After subgroup analysis, coronary heart disease was found to be related to mortality (OR=3.75, 95%CI [2.91, 4.82], P<0.001), severe/critical COVID-19 (OR=3.23, 95%CI [2.19, 4.77], P<0.001), ICU admission (OR=2.25, 95%CI [1.34, 3.79], P=0.002), disease progression (OR=3.01, 95%CI [1.46, 6.22], P=0.003); Meta-regression showed that the association between coronary heart disease and poor prognosis of COVID-19 was affected by hypertension (P=0.004), and subgroup analysis showed that compared with the proportion of hypertension >30% (OR=2.85, 95%CI [2.33, 3.49]), the proportion of hypertension <30% (OR=4.78, 95%CI [3.50, 6.51]) had a higher risk of poor prognosis.ConclusionCoronary heart disease is a risk factor for poor prognosis in patients with COVID-19. (AU)

Objetivo: Desde que la Organización Mundial de la Salud (OMS) anunció que la enfermedad por coronavirus de 2019 (COVID-19) se había convertido en una pandemia global el 11 de marzo de 2020, se ha incrementado el número de infecciones. El objetivo de este metaanálisis fue investigar el pronóstico de la COVID-19 en pacientes con cardiopatía coronaria.MétodoSe realizó una búsqueda en las bases de datos de Pubmed, Embase y Cochrane Library para reunir la literatura relativa a cardiopatía coronaria y COVID-19. El tiempo de recuperación de datos fue desde el inicio hasta el 20 de noviembre de 2020, utilizando la versión 14.0 de Stata® para el metaanálisis.ResultadosSe incluyó un total de 22.148 pacientes de 40 estudios. El metaanálisis reveló que la cardiopatía coronaria estaba asociada a un mal pronóstico de COVID-19 (OR: 3,42; IC 95%: 2,83-4,13; p<0,001). Tras el análisis de subgrupo, se encontró que la cardiopatía coronaria tenía relación con la mortalidad (OR: 3,75; IC 95%: 2,91-4,82; p<0,001), COVID-19 grave/crítica (OR: 3,23; IC 95%: 2,19-4,77; p<0,001), ingreso en la UCI (OR: 2,25; IC 95%: 1,34-3,79; p=0,002), progresión de la enfermedad (OR: 3,01; IC 95%: 1,46-6,22; p=0,003). La metarregresión reflejó que la asociación entre cardiopatía coronaria y mal pronóstico de la COVID-19 estaba influida por la hipertensión (p=0,004), y el análisis de subgrupo mostró que comparada con la proporción de hipertensión >30% (OR: 2,85; IC 95%: 2,33-3,49), la proporción de hipertensión <30% (OR: 4,78; IC 95%: 3,50-6,51) tenía mayor riesgo de mal pronóstico.ConclusiónLa cardiopatía coronaria es un factor de riesgo de mal pronóstico en pacientes con COVID-19. (AU)

Coronary heart disease and COVID-19: A meta-analysis.

OBJECTIVE: Since the World Health Organization (WHO) announced coronavirus disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number of infections has been increasing. The purpose of this meta-analysis was to investigate the prognosis of COVID-19 in patients with coronary heart disease. METHOD: Pubmed, Embase, and Cochrane Library databases were searched to collect the literature concerning coronary heart disease and COVID-19. The retrieval time was from inception to Nov 20, 2020, using Stata version 14.0 for meta-analysis. RESULTS: A total of 22,148 patients from 40 studies were included. The meta-analysis revealed that coronary heart disease was associated with poor prognosis of COVID-19 (OR=3.42, 95%CI [2.83, 4.13], P<0.001). After subgroup analysis, coronary heart disease was found to be related to mortality (OR=3.75, 95%CI [2.91, 4.82], P<0.001), severe/critical COVID-19 (OR=3.23, 95%CI [2.19, 4.77], P<0.001), ICU admission (OR=2.25, 95%CI [1.34, 3.79], P=0.002), disease progression (OR=3.01, 95%CI [1.46, 6.22], P=0.003); Meta-regression showed that the association between coronary heart disease and poor prognosis of COVID-19 was affected by hypertension (P=0.004), and subgroup analysis showed that compared with the proportion of hypertension >30% (OR=2.85, 95%CI [2.33, 3.49]), the proportion of hypertension <30% (OR=4.78, 95%CI [3.50, 6.51]) had a higher risk of poor prognosis. CONCLUSION: Coronary heart disease is a risk factor for poor prognosis in patients with COVID-19.

Experimental investigations of drilling temperature of high-energy ultrasonically assisted bone drilling.

Ultrasonically assisted drilling as a new type of bone drilling technology has received increasing attention. However, the vibration energy of existing studies was limited. In this study, a robot-based ultrasonically assisted bone drilling experimental setup was designed, and high-energy ultrasonically assisted bone drilling (vibration frequency=24.1-41 kHz, and vibration amplitude=150-160 µm) was applied to bovine cortical bone to investigate the drilling temperature compared with conventional drilling. The effect of drilling speed on drilling temperature was also studied. The experiment results showed that, compared with the conventional bone drilling, high-energy ultrasonically assisted bone drilling had slightly higher drilling temperature (0.36-0.86 °C), which is in direct contrast to previous reports. We hypothesized that this finding was due to the thermal effect of ultrasonic vibration, which the present study confirmed. Moreover, the drilling temperature increased with higher drilling speed.